scispace - formally typeset
Journal ArticleDOI

Preparation and characterization of solid lipid nanoparticles containing silibinin.

Reads0
Chats0
TLDR
Stealth solid lipid nanoparticles were stable without precipitation of silibinin on storage conditions and can be proposed for their parenteral administration.
Abstract
The study describes the development of stealth solid lipid nanoparticles (SLNs) as colloidal carriers for silibinin, a drug with very low solubility. Stealth SLNs were constituted mainly of bioacceptable and biodegradable lipids, such as stearic acid and surfactant Brij 78 (polyoxyethylene 20 stearyl ether) and can incorporate amounts of silibinin up to 7.55%. Stealth-loaded SLNs were in the nanometer size range. Thermal analysis (differential scanning calorimetry) showed that silibinin was dispersed in the stealth SLNs at an amorphous state. Release of silibinin from stealth SLNs was very slow. Stealth SLNs were stable without precipitation of silibinin on storage conditions and can be proposed for their parenteral administration.

read more

Citations
More filters
Journal Article

Reassessing bioavailability of silymarin.

TL;DR: This article critically reviews the recent published literature on various techniques for increasing the bioavailability of silymarin and describes an array of methods that can improve its bioavailability.
Journal ArticleDOI

Design and Development of Nanovehicle-Based Delivery Systems for Preventive or Therapeutic Supplementation with Flavonoids

TL;DR: A comprehensive review of studies currently available on the in vitro and in vivo experimental administration of flavonoids by means of nanovectors may be of use as a foundation for the development of advanced delivery systems for these powerful compounds, in view of their adoption in primary and secondary disease prevention.
Journal ArticleDOI

Design and Evaluation of a Novel Evodiamine-Phospholipid Complex for Improved Oral Bioavailability

TL;DR: A novel evodiamine (EVO)-phospholipid complex (EPLC) was designed to improve the bioavailability of EVO and the relative bioavailability was significantly increased to 218.82 % compared with that ofEVO.
Journal ArticleDOI

Oral Apomorphine Delivery from Solid Lipid Nanoparticles with Different Monostearate Emulsifiers: Pharmacokinetic and Behavioral Evaluations

TL;DR: The experimental results suggest that SLNs may offer a promising strategy for apomorphine delivery via oral ingestion, and show 12- to 13-fold higher bioavailability than the reference solution.
Journal ArticleDOI

Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer

TL;DR: Nanosuspension could serve as a promising intravenous drug-delivery system for curcumin to improve its solubility and change its in vivo behavior.
References
More filters
Journal ArticleDOI

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

TL;DR: Relevant issues for the introduction of SLN to the pharmaceutical market, such as status of excipients, toxicity/tolerability aspects and sterilization and long-term stability including industrial large scale production are discussed.
Journal ArticleDOI

Biodegradable long-circulating polymeric nanospheres

TL;DR: Monodisperse biodegradable nanospheres were developed from amphiphilic copolymers composed of two biocompatible blocks and exhibited dramatically increased blood circulation times and reduced liver accumulation in mice.
Journal ArticleDOI

Analysis of Macromolecular Polydispersity in Intensity Correlation Spectroscopy: The Method of Cumulants

TL;DR: The first order electric field correlation function of laser light scattered by polydisperse solutions of macromolecules can be written as a sum or distribution of exponentials, with decay rates proportional to the diffusion coefficients of the solute molecules as discussed by the authors.
Journal ArticleDOI

Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system

TL;DR: The literature reviewed provides enough promise for anticipating therapeutic and diagnostic applications of surface-modified nanoparticles, with particular focus on the literature concerning particles other than liposomes.
Journal ArticleDOI

Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanism

TL;DR: The principle suitability of SLN as a prolonged release formulation for lipophilic drugs is demonstrated and tetracaine and prednisolone loaded SLN showed a distinctly prolonged release over a monitored period of 5 weeks.
Related Papers (5)